Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 199

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 1
Chunk 199
---
27

			12/28/18

			232

			-

			C
			
			$
			15.12

			12/28/28

			2/12/20

			9,856

			-

			$
			22.12

			2/12/30

			10/13/20

			7,143

			-

			$
			52.08

			10/13/30

			4/22/21

			11,429

			-

			$
			38.18

			4/22/31

			2/28/22

			6,215

			$
			25.97

			2/28/32

			7/20/23

			8,576

			2,853
			(2) 

			$
			5.79

			7/20/33

			5/29/25

			110,908
			(3) 
			 
			$
			273,943

			5/29/25

			57,440
			(2) 
			 
			$
			141,877

			Peter Weiler

			5/29/25

			57,792
			(2) 
			 
			$
			142,746

			(1)

			Our options and RSU vesting policy is described in the Outstanding Equity Awards Narrative Disclosure section.

			(2)

			The option and RSUs vest over a period of three years, with monthly vesting on a pro-rata basis beginning on the date of grant.

			(3)
			The RSUs vest over a period of 18 months, with monthly vesting on a pro-rate basis beginning on the date of grant.

			(4)
			The RSUs vest over a period of 24 months, with monthly vesting on a pro-rate basis beginning on the date of grant.

			(5) 

			Represents the product of (i) $2.47 (which was the closing price of the common shares on September 30, 2025, the last trading day of fiscal 2025) and (ii) the number of common shares underlying the RSUs.

60

Outstanding Equity